Conspiracy theories and cognitive biases in the COVID-19 pandemic

  Basel, Switzerland (April 7, 2021) — Conspiracy theories appear to be increasing in popularity as the Covid-19 pandemic continues. But to what extent do people really agree with them, and what is the association with cognitive biases? A research team from the University of Basel studied these questions in German-speaking Switzerland and Germany. Periods
WEITERLESEN »

New Lyme disease test distinguishes between early and late-stage disease

New test targets genetic sequences in Lyme-causing bacteria and is highly sensitive, detecting just one bacterial cell in a blood sample   (April 7, 2021) — For those who live in an area blighted by ticks, the threat of Lyme disease can cast a shadow over the joy of spring and summer. These blood-sucking arachnids
WEITERLESEN »

Study shows why crossing obstacles is difficult for patients with Parkinson’s disease

  Bauru, Brazil (April 7, 2021) – A multidisciplinary research group affiliated with the Department of Physical Education’s Human Movement Laboratory (Movi-Lab) at São Paulo State University (UNESP) in Bauru, Brazil, measured step length synergy while crossing obstacles in patients with Parkinson’s disease and concluded that it was 53% lower than in healthy subjects of
WEITERLESEN »

Cost-effective, easily manufactured ventilators for COVID-19 patients

The Mechanical Ventilator Milano design helps overcome the ventilator shortage, aids with the respiratory effects of the pandemic.   WASHINGTON, USA (March 23, 2021) — Scientists have been working for the past year to find ways to curb the effects of the COVID-19 pandemic. Though it is outside their typical realm of study, physicists have
WEITERLESEN »

New diagnostic tool for the management of patients with sepsis

  Hennigsdorf/Berlin, Germany (March 23, 2021) — Diagnostics company SphingoTec GmbH („SphingoTec“) announced today the first published data (1) on the biomarker DPP3 that can predict the evolution of organ function and survival in septic patients. Measured on top of routinely used standard parameters, such as Lactate and Procalcitonin, DPP3 is an early indicator of
WEITERLESEN »

The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia

  Washington,DC, USA (March 23, 2021) — In Slovakia, in counties subject to two rounds of rapid antigen testing for SARS-CoV-2 where those who tested positive then isolated, the approach helped decrease the prevalence of positive tests by more than 50% in a week – all while primary schools and workplaces remained open. „While it
WEITERLESEN »

Pilot study finds evidence of bartonella infection in schizophrenia patients

  Raleigh, NC, USA (March 23, 2021) — A pilot study from North Carolina State University and the University of North Carolina at Chapel Hill has found evidence of Bartonella infection in the blood of people with schizophrenia and schizoaffective disorder. „Researchers have been looking at the connection between bacterial infection and neuropsychiatric disease for
WEITERLESEN »

Hospitalized COVID-19 patients with obesity are significantly more likely to need ICU care

Study did not find higher risk of death in people with obesity, COVID-19   WASHINGTON, USA (March 20, 2021) — People with obesity who are hospitalized with COVID-19 have a significantly higher rate of ICU admissions and longer duration of ICU stay compared to people with a normal body mass index (BMI), according to a
WEITERLESEN »

Certain mouthwashes might stop COVID-19 virus transmission

A Rutgers study shows two types of mouthwash disrupt SARS-CoV-2 in laboratory   New Brunswick, NJ, USA (March 17, 2021) — Researchers at Rutgers School of Dental Medicine have found evidence that two types of mouthwash disrupt the COVID-19 virus under laboratory conditions, preventing it from replicating in a human cell. The study, published in
WEITERLESEN »

High speed air hand dryers spread contamination more than paper towels

Experiment shows air dryers spread bacteria from poorly washed hands to clothing and surfaces beyond the restroom   NEW YORK, USA (March 17, 2021) — High speed air dryers not only leave more contamination on poorly washed hands compared to paper towels, but during hand drying, they can also spread germs onto clothing, ultimately transferring
WEITERLESEN »

Nurse work environment influences stroke outcomes

  PHILADELPHIA, USA (March 17, 2021) – Stroke remains a leading cause of death worldwide and one of the most common reasons for disability. While a wide variety of factors influence stroke outcomes, data show that avoiding readmissions and long lengths of stay among ischemic stroke patients has benefits for patients and health care systems
WEITERLESEN »

Aspirin use may decrease ventilation, ICU admission and death in COVID-19 patients

Researchers from the George Washington University found that aspirin may have lung-protective effects and reduce the need for mechanical ventilation, ICU admission and in-hospital mortality in hospitalized COVID-19 patients   Washington, DC (March 17, 2021) — George Washington University researchers found low dose aspirin may reduce the need for mechanical ventilation, ICU admission and in-hospital
WEITERLESEN »

Ultrasound has potential to damage coronaviruses, study finds

Simulations show ultrasound waves at medical imaging frequencies can cause the virus‘ shell and spikes to collapse and rupture   Cambridge, MA, USA (March 17, 2021) — The coronavirus‘ structure is an all-too-familiar image, with its densely packed surface receptors resembling a thorny crown. These spike-like proteins latch onto healthy cells and trigger the invasion
WEITERLESEN »

Full evolutionary journey of hospital superbug mapped for the first time

  Hinxton, Cambridgeshire, UK (March 9, 2021) — Modern hospitals and antibiotic treatment alone did not create all the antibiotic resistant strains of bacteria we see today. Instead, selection pressures from before widespread use of antibiotics influenced some of them to develop, new research has discovered. By using analytical and sequencing technology that has only
WEITERLESEN »

A new predictive model helps identify those at risk for severe COVID-19

Buck scientists analyze data from 3 million people using a smartphone app in the United Kingdom   Novato, CA, USA (March 9, 2021) — Researchers at the Buck Institute analyzed data from the COVID-19 Symptom Tracker app used by 3 million people in the United Kingdom, adding the use of immunosuppressant medication, use of a
WEITERLESEN »

Study reveals new hope for men with common urinary issues

  Leawood, KS, USA (March 9, 2021) — A new systematic review of evidence recommends the use of behavioral self-management treatments for common urinary issues experienced by upwards of 70 percent of older men. Common symptoms include trouble urinating, increased frequency and incontinence. These symptoms can have a substantial negative impact on sleep, social functioning
WEITERLESEN »

Treating incontinence in primary care: A doctor versus mobile app trial

Treating incontinence in primary care: A doctor versus mobile app trial App-based treatment in primary care for urinary incontinence: A pragmatic, randomized controlled trial   Leawood, KS, USA (March 9, 2021) — A mobile app designed to help women manage urinary incontinence was as effective as usual, in-person treatment of incontinence in primary care, according
WEITERLESEN »

Targeted immunotherapy could boost radiotherapy response

  London, UK (March 7, 2021) — Cancers that are resistant to radiotherapy could be rendered susceptible through treatment with immunotherapy, a new study suggests. Researchers believe that manipulating bowel cancers based on their ‚immune landscape‘ could unlock new ways to treat resistant tumours. Cancers can evolve resistance to radiotherapy just as they do with
WEITERLESEN »

After old age, intellectual disability is greatest risk factor for death from COVID-19

A study of national data shows the devastating impact the pandemic has had on those with intellectual disabilities and their caregivers.   PHILADELPHIA, USA (March 5, 2021) — Intellectual disability puts individuals at higher risk of dying earlier in life than the general population, for a variety of medical and institutional reasons. A new study
WEITERLESEN »

New Corona test developed

Researchers develop a low-cost and fast method to detect a COVID-19 infection from a pool of gargle lavage samples   Leipzig, Germany (march 5, 2021) — Quantitative real-time polymerase chain reaction (qPCR) is the most widely used diagnostic method to detect RNA viruses such as SARS-CoV-2. However, it requires expensive laboratory equipment and global shortages
WEITERLESEN »

Smoking cessation drug may treat Parkinson’s in women

Texas A&M researchers have found that that cytisine can reduce dopamine neuron loss, providing a protective effect against the neurodegenerative disorder.   (March 4, 2021) — Texas A&M University College of Medicine ressearchers have recently discovered that cytisine — a smoking cessation drug commonly used in Europe — reduces the loss of dopamine neurons in
WEITERLESEN »

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 February 2021

  Six new medicines recommended for approval Amsterdam, The Netherlands (February 26, 2021) — EMA’s human medicines committee (CHMP) recommended six medicines for approval at its February 2021 meeting. The Committee recommended granting a marketing authorisation for Evrysdi* (risdiplam), the first treatment that can be given orally to patients with certain types of spinal muscular
WEITERLESEN »

Using face masks in the community: first update – Effectiveness in reducing transmission of COVID-19

Using face masks in the community: first update – Effectiveness in reducing transmission of COVID-19   Solna, Sweden (February 15, 2021) — This technical report reviews the evidence that has been accumulated since the emergence of COVID-19, in addition to what has existed on this topic prior to the pandemic, and updates the ECDC opinion
WEITERLESEN »

Difficulties to care for ICU patients caused by COVID-19

  Seville, Espagna (February 10, 2021) — Researchers from the University of Seville’s Nursing Department, with the collaboration of professionals from the ICU at Virgen Macarena University Hospital in Seville, have analysed the key factors in caring for critical COVID-19 patients during the first wave of the pandemic. Their study concludes that nursing care was
WEITERLESEN »

Virtual post-sepsis recovery program may also help recovering COVID-19 patients

  New York, NY, USA (Feb. 10, 2021) — A new paper published online in the Annals of the American Thoracic Society describes a „virtual“ recovery program for sepsis patients that may also help post-COVID-19 patients and survivors of other serious illnesses. In „Translating Post-Sepsis Care to Post-COVID Care: The Case for a Virtual Recovery
WEITERLESEN »

‚Sleep hygiene‘ should be integrated into epilepsy diagnosis and management

  Children with epilepsy sleep poorly compared to healthy children, and are more likely to experience disruptions such as night terrors, sleep walking or sleep disordered breathing, according to a new study. A team at the University of Birmingham’s Centre for Human Brain Health analysed 19 published studies on sleep and epilepsy in children and
WEITERLESEN »

Case Western Reserve-led team finds that people with dementia at higher risk for COVID-19

  CLEVELAND, Ohio, USA (Feb. 9, 2021) — A study led by Case Western Reserve University researchers found that patients with dementia were at a significantly increased risk for COVID-19–and the risk was higher still for African Americans with dementia. Reviewing electronic health records of 61.9 million adults in the United States, researchers found the
WEITERLESEN »

Cancer leading cause of death among people with diabetes

  London, UK (February 4, 2021) — This is the finding of an 18-year-study of over 300,000 people with diabetes in England, from scientists from Imperial College London and published in the journal The Lancet Diabetes & Endocrinology. Thursday Feb 4th is World Cancer Day. The research, funded by the Wellcome Trust, reveals that between
WEITERLESEN »

Study finds recommended ICU sedatives equally safe, effective

  Nashville, Tennessee, USA (February 2, 2021) — Sedative medications used in intensive care are associated with increased delirium, which is in turn connected with higher medical costs and greater risk of death and ICU-related dementia. A study published today in the New England Journal of Medicine provides the most definitive evidence to date that,
WEITERLESEN »

Lack of ICU beds tied to thousands of excess COVID-19 deaths, Yale study finds

  New Haven, Conn., USA (February 2, 2021) — A new study by Yale researchers found a significant association between the availability of hospital resources — particularly ICU beds — and patient mortality during the early weeks of the COVID-19 pandemic. This was especially true at hospitals in the northeastern U.S. which were hardest hit
WEITERLESEN »

Guidelines for extracorporeal cardiopulmonary resuscitation in children and adults: New ELSO statements in ASAIO Journal

  (February 1, 2021) — Extracorporeal cardiopulmonary resuscitation (ECPR) is a potentially lifesaving treatment for patients in cardiac arrest when the circulation can’t be restored by conventional CPR. New guidelines for ECPR in adults and children, developed by the Extracorporeal Life Support Organization (ELSO), are presented by the ASAIO Journal, official journal of the American
WEITERLESEN »

Prostate drug associated with lower risk of Parkinson’s disease

  Iowa City, Iowa, USA (February 1, 2021) — Taking a particular type of medication to treat enlarged prostate is associated with a reduced risk of developing Parkinson’s disease, according to a large observational study led by researchers at the University of Iowa, with colleagues in Denmark and China. The findings, published Feb. 1 in
WEITERLESEN »

Genetic screening before prescribing could benefit millions

  Norwich, UK (January 29, 2021) — Four million UK patients could benefit annually from genetic testing before being prescribed common medicines, according to new research from the University of East Anglia (UEA) in collaboration with Boots UK and Leiden University (Netherlands). Researchers looked through 2019 NHS dispensing data across the UK to see how
WEITERLESEN »

Metformin may affect risk of breast cancer in women with type 2 diabetes

  (January 28, 2021) — A study of 44,541 women has found that there appears to be no association between type 2 diabetes and developing breast cancer overall. This may be because most women in the study with type 2 diabetes were taking metformin, a medication widely used to treat type 2 diabetes, whose actions
WEITERLESEN »

Heparin targets coronavirus spike protein, research shows

Common anticoagulant drug could be repurposed for Covid-19 treatment   Liverpool, UK (January 28, 2021) — An international team of researchers led by the Universities of Liverpool and Keele, working with Public Health England, has found that the common anticoagulant drug heparin inhibits the SARS-Cov2 virus spike protein, by reducing the virus‘ ability to attach
WEITERLESEN »

How coronavirus damages lung cells within mere hours

Multipronged BU research team finds 18 FDA-approved drugs that could halt coronavirus infection earlier   Boston, Massachusetts; USA (January 28, 2021) — What if scientists knew exactly what impact the SARS-CoV-2 virus had inside our lung cells, within the first few hours of being infected? Could they use that information to find drugs that would
WEITERLESEN »

Hypertension symptoms in women often mistaken for menopause

  Sophia Antipolis, France (January 27, 2021) —  Pregnancy complications and early menopause increase women’s future risk of heart disease. Cardiologists, gynaecologists and endocrinologists recommend how to help middle-aged women prevent later heart problems in a European Society of Cardiology (ESC) consensus document published today in European Heart Journal, a journal of the ESC.1 „Physicians
WEITERLESEN »

90-day vaginal ring shows promise as method for preventing both HIV and pregnancy

Results of second early phase study of the ring containing dapivirine and a contraceptive are encouraging but also indicate a need for reformulation   PITTSBURGH (26 January 2021) — A vaginal ring containing the antiretroviral drug dapivirine and the contraceptive hormone levonorgestrel delivered sustained levels of each drug when used continuously for 90 days –
WEITERLESEN »

Research shows people with high omega-3 index less likely to die from COVID-19

Pilot study shows positive outcomes for those suffering from COVID-19   Sioux Falls, South Dakota, USA (January 26, 2021) — Researchers with the Fatty Acid Research Institute (FARI) and collaborators at Cedars-Sinai Medical Center in Los Angeles and in Orange County, CA, have published the first direct evidence that higher omega-3 blood levels may reduce
WEITERLESEN »

Over half of cannabis users with Parkinson’s disease report clinical benefits

A survey in Germany found over 8% of patients with Parkinson’s disease are using cannabis products and more than half experienced beneficial clinical effects, reports the Journal of Parkinson’s Disease   Amsterdam, NL (January 26, 2021) — With medicinal cannabis now legalized in many parts of the world, there is growing interest in its use
WEITERLESEN »

Fitness watches generate useful information, but increase patient anxiety

  Copenhagen, Denmark (August 4, 2020) — How does measuring our sleep, exercise and heart rates using various apps and fitness watches affect us? Self-quantifying may better the understanding of our individual health, but according to a new study, it also gives rise to anxiety. Is my heart beating slightly fast? Is a heart attack
WEITERLESEN »

A new device provides added protection against COVID-19 during endoscopic procedures

  Sendai, Japan (July 22, 2020) — The COVID-19 pandemic has thrown up unimaginable challenges for healthcare workers. Even simple outpatient procedures such as endoscopies can expose staff to the risk of infection. However, a team of researchers has developed a simple, disposable, and inexpensive device to provide an additional barrier of protection for healthcare
WEITERLESEN »

81 million Americans lacking space or bathrooms to follow COVID quarantine recommendations

  Inadequate room for quarantine/isolation much more common among minorities hardest hit by pandemic, worsening spread within families   Chicago, IL, USA (July 21, 2020) — An article published today in the Annals of Internal Medicine reports that 25 million dwellings that house 81 million Americans lack adequate space or plumbing to allow compliance with
WEITERLESEN »

Front-line physicians stressed and anxious at work and home

  New study reports moderate to severe stress levels in ER doctors during the frenetic early phase of COVID-19 pandemic   San Francisco, CA, USA (July 21, 2020) — Amid the COVID-19 chaos in many hospitals, emergency medicine physicians in seven cities around the country experienced rising levels of anxiety and emotional exhaustion, regardless of
WEITERLESEN »

EULAR: High-Dose Glucocorticoids and IL-6 Receptor inhibition can reduce COVID-19 associated Cytokine Storm related hospital mortality by 65%

  Kilchberg, Switzerland (July 21, 2020) — Findings of a new study show that a widely available immunosuppressant used for treatment of rheumatic musculoskeletal diseases (RMDs) accelerates respiratory recovery, lowers hospital-mortality and reduces the likelihood of invasive mechanical ventilation compared to supportive care only. The Annals of the Rheumatic Diseases, ARD, the journal of the
WEITERLESEN »

Genetic markers are useful in predicting osteoporotic fracture risk

Findings hold potential for cost savings while improving efficiency of screening Boston, MA, USA (July 20, 2020) — A new study shows that genetic pre-screening could reduce the number of screening tests needed to identify individuals at risk for osteoporotic fractures. Douglas P. Kiel, M.D., M.P.H., director of the Musculoskeletal Research Center in the Hinda
WEITERLESEN »

„Love hormone“ oxytocin could be used to treat cognitive disorders like Alzheimer’s

Scientists discover for the first time that oxytocin could be a potential new therapeutic option for cognitive disorders such as Alzheimer’s disease Tokyo, Japan (July 20, 2020) — Alzheimer’s disease is a progressive disorder in which the nerve cells (neurons) in a person’s brain and the connections among them degenerate slowly, causing severe memory loss,
WEITERLESEN »

Does having Alzheimer’s disease and dementia affect severity of delirium?

  New York, NY; USA (July 17, 2020) — Forms of dementia, including Alzheimer’s disease, gradually affect your cognitive function by harming your memory and your ability to think and make decisions. By 2050, experts project that 13.8 million older adults in the United States will develop Alzheimer’s disease and related Dementias (ADRD). Although Alzheimer’s
WEITERLESEN »

Study finds hidden emotions in the sound of words

ITHACA, N.Y., USA (July 14, 2020) – – In the midst of the COVID-19 crisis, it’s common to feel stress levels rise every time we hear the word „virus.“ But new Cornell-led research reveals that the sound of the word itself was likely to raise your blood pressure – even before „corona“ was added to
WEITERLESEN »

Cystic fibrosis: why so many respiratory complications?

  By demonstrating the key role of Vav3 protein, UNIGE researchers highlight how the protein Vav3 creates bacterial docking stations to facilitate lung infections in cystic fibrosis.   Geneva, Switzerland (July 13, 2020) — Cystic fibrosis, one of the most common genetic diseases in Switzerland, causes severe respiratory and digestive disorders. Despite considerable therapeutic advances,
WEITERLESEN »

MEDICAL NEWS

IU School of Medicine researchers develop blood test for anxiety
COVID-19 pandemic increased rates and severity of depression, whether people…
COVID-19: Bacterial co-infection is a major risk factor for death,…
Regenstrief-led study shows enhanced spiritual care improves well-being of ICU…
Hidden bacteria presents a substantial risk of antimicrobial resistance in…

SCHMERZ PAINCARE

Hydromorphon Aristo® long ist das führende Präferenzpräparat bei Tumorschmerz
Sorgen und Versorgen – Schmerzmedizin konkret: „Sorge als identitätsstiftendes Element…
Problem Schmerzmittelkonsum
Post-Covid und Muskelschmerz
Kopfschmerz bei Übergebrauch von Schmerz- oder Migränemitteln

DIABETES

Wie das Dexom G7 abstrakte Zahlen mit Farben greifbar macht…
Diabetes mellitus: eine der großen Volkskrankheiten im Blickpunkt der Schmerzmedizin
Suliqua®: Einfacher hin zu einer guten glykämischen Kontrolle
Menschen mit Diabetes während der Corona-Pandemie unterversorgt? Studie zeigt auffällige…
Suliqua® zur Therapieoptimierung bei unzureichender BOT

ERNÄHRUNG

Positiver Effekt der grünen Mittelmeerdiät auf die Aorta
Natriumaufnahme und Herz-Kreislaufrisiko
Tierwohl-Fleisch aus Deutschland nur mäßig attraktiv in anderen Ländern
Diät: Gehirn verstärkt Signal an Hungersynapsen
Süßigkeiten verändern unser Gehirn

ONKOLOGIE

Strahlentherapie ist oft ebenso effizient wie die OP: Neues vom…
Zanubrutinib bei chronischer lymphatischer Leukämie: Zusatznutzen für bestimmte Betroffene
Eileiter-Entfernung als Vorbeugung gegen Eierstockkrebs akzeptiert
Antibiotika als Störfaktor bei CAR-T-Zell-Therapie
Bauchspeicheldrüsenkrebs: Spezielle Diät kann Erfolg der Chemotherapie beeinflussen

MULTIPLE SKLEROSE

Multiple Sklerose: Aktuelle Immunmodulatoren im Vergleich
Neuer Biomarker für Verlauf von Multipler Sklerose
Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?

PARKINSON

Meilenstein in der Parkinson-Forschung: Neuer Alpha-Synuclein-Test entdeckt die Nervenerkrankung vor…
Neue Erkenntnisse für die Parkinson-Therapie
Cochrane Review: Bewegung hilft, die Schwere von Bewegungssymptomen bei Parkinson…
Technische Innovationen für eine maßgeschneiderte Parkinson-Diagnostik und Therapie
Biomarker und Gene: neue Chancen und Herausforderungen für die Parkinson-Diagnose…